Phase 1 Dose Escalation Study With Sorafenib in Combination With Sirolimus in Patients With Solid Tumor.
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2009
At a glance
- Drugs Sirolimus; Sorafenib
- Indications Solid tumours
- Focus Adverse reactions
- 23 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2007 New trial record.